Featured Press Releases

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

Emulate introduces the AVA™ Emulation System, a groundbreaking high-throughput organ-chip platform designed to accelerate drug development

Emulate introduces the AVA™ Emulation System, a groundbreaking high-throughput organ-chip platform designed to accelerate drug development

  • 10 Jun 2025

Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial...

Connected Pill Box Unveiled by Hello Heart to Radically Improve Medication Adherence

Connected Pill Box Unveiled by Hello Heart to Radically Improve Medication Adherence

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Health Canada has granted Celltrion approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg).

Health Canada has granted Celltrion approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg).

MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

  • Spectrum Science
  • 08 Jul 2026
Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

  • Omega Laboratories, Inc.
  • 08 Jul 2026
Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

  • Organon
  • 07 Jul 2026
European Commission Approves AbbVie

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • AbbVie
  • 06 Jul 2026
Nnamdi Njoku Named President of Omnicell

Nnamdi Njoku Named President of Omnicell

  • Omnicell, Inc.
  • 01 Jul 2026
Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

  • Novo Nordisk
  • 01 Jul 2026
The Digital Pharma Advances Conference 2026

Most Popular
July   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.